3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
44
Colorectal Neoplasms
22
Breast Neoplasms
22
Stomach Neoplasms
21
Neoplasms
18
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
11
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Rectal Neoplasms
9
Colonic Neoplasms
8
Pancreatic Neoplasms
7
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Osteosarcoma
5
Brain Neoplasms
5
Small Cell Lung Carcinoma
4
Recurrence
4
Glioblastoma
4
Gastrointestinal Neoplasms
4
Precision Cell Immunotherapy
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Head and Neck Neoplasms
3
Gastrointestinal Diseases
3
Digestive System Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Interventions
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
3
Capecitabine
3
Tegafur
2
Stents
2
Radiofrequency Ablation
2
Leucovorin
2
Irinotecan
2
toripalimab
1
tislelizumab
1
taxane
1
surufatinib
1
lenvatinib
1
apixaban
1
apatinib
1
aldesleukin
1
Urination
1
Trastuzumab
1
Tomography, X-Ray Computed
1
Temozolomide
1
Taxes
1
Standard of Care
1
Sorafenib
1
S 1 (combination)
1
Rivaroxaban
1
Radiotherapy
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gallbladder Neoplasms
×
Drug Therapy
×
Clear all
NCT04333927
2020-06-23
ACCORD
Sun Yat-sen University
Phase 2
Unknown
92 enrolled